Exacerbation of myasthenia gravis during interferon-alpha treatment.
Uyama
E
E
Fujiki
N
N
Uchino
M
M
D000328:Adult; D006526:Hepatitis C / Q000188:drug therapy*; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced*; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins